journal
https://read.qxmd.com/read/26005701/enhancement-of-osteoblastogenesis-and-suppression-of-osteoclastogenesis-by-inhibition-of-de-phosphorylation-of-eukaryotic-translation-initiation-factor-2-alpha
#21
Kazunori Hamamura, Andy Chen, Hiroki Yokota
The phosphorylation of eukaryotic translation initiation factor 2 alpha (eIF2α) is activated in response to various stresses such as viral infection, nutrient deprivation, and stress to the endoplasmic reticulum. Severe stress to the endoplasmic reticulum, for instance, induces an apoptotic pathway, while mild stress, on the contrary, leads to a pro-survival pathway. Little has been known about the elaborate role of eIF2α phosphorylation in the development of bone-forming osteoblasts and bone-resorbing osteoclasts...
2015: Receptors & Clinical Investigation
https://read.qxmd.com/read/26005700/uncovering-unique-roles-of-lpa-receptors-in-the-tumor-microenvironment
#22
Sue-Chin Lee, Yuko Fujiwara, Gabor J Tigyi
The role of the lysophospholipase D autotaxin (ATX) and lysophosphatidic acid (LPA) in cancer is emerging and represents two key players in regulating cancer progression. In this brief review, we will discuss some of our recent findings, which highlight a central role that LPA and its receptor plays in orchestrating melanoma-stroma interactions in the establishment of lung metastases. In particular, we evaluated not only the function of LPA receptors on tumor cells but also their role on host tissues and how they can influence melanoma growth and metastasis...
2015: Receptors & Clinical Investigation
https://read.qxmd.com/read/25646163/regulation-of-ryanodine-receptor-mediated-calcium-signaling-by-presenilins
#23
Andrew J Payne, Simon Kaja, Peter Koulen
No abstract text is available yet for this article.
2015: Receptors & Clinical Investigation
https://read.qxmd.com/read/25938125/in-vivo-neuronal-co-expression-of-mu-and-delta-opioid-receptors-uncovers-new-therapeutic-perspectives
#24
Eric Erbs, Lauren Faget, Pierre Veinante, Brigitte L Kieffer, Dominique Massotte
Opioid receptors belong to the G protein coupled receptor family. They modulate brain function at all levels of neural integration and therefore impact on autonomous, sensory, emotional and cognitive processing. In vivo functional interaction between mu and delta opioid receptors are known to take place though it is still debated whether interactions occur at circuitry, cellular or molecular level. Also, the notion of receptor crosstalk via mu-delta heteromers is well documented in vitro but in vivo evidence remains scarce...
September 2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/25493288/the-multiple-signaling-modalities-of-adhesion-g-protein-coupled-receptor-gpr126-in-development
#25
Chinmoy Patra, Kelly R Monk, Felix B Engel
The G protein-coupled receptor (GPCR) superfamily is the largest known receptor family in the human genome. Although the family of adhesion GPCRs comprises the second largest sub-family, their function is poorly understood. Here, we review the current knowledge about the adhesion GPCR family member GPR126. GPR126 possesses a signal peptide, a 7TM domain homologous to secretin-like GPCRs, a GPS motif and an extended N-terminus containing a CUB (Complement, Uegf, Bmp1) domain, a PTX (Pentraxin) domain, a hormone binding domain and 27 putative N-glycosylation sites...
July 1, 2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/26046097/arfgaps-key-regulators-for-receptor-sorting
#26
JOURNAL ARTICLE
Yoko Shiba, Paul A Randazzo
Mammalian cells have many membranous organelles that require proper composition of proteins and lipids. Cargo sorting is a process required for transporting specific proteins and lipids to appropriate organelles, and if this process is disrupted, organelle function as well as cell function is disrupted. ArfGAP family proteins have been found to be critical for receptor sorting. In this review, we summarize our recent knowledge about the mechanism of cargo sorting that require function of ArfGAPs in promoting the formation of transport vesicles, and discuss the involvement of specific ArfGAPs for the sorting of a variety of receptors, such as MPR, EGFR, TfR, Glut4, TRAIL-R1/DR4, M5 -muscarinic receptor, c-KIT, rhodopsin and β1-integrin...
June 13, 2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/37621573/fibronectin-signaling-via-toll-like-receptprs-a-novel-paradigm-for-persistent-fibrosis-in-scleroderma
#27
JOURNAL ARTICLE
Swati Bhattacharyya, John Varga
No abstract text is available yet for this article.
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/26078987/role-of-protease-activated-receptors-2-par2-in-ocular-infections-and-inflammation
#28
Trivendra Tripathi, Hassan Alizadeh
Protease-activated receptors (PARs) belong to a unique family of G protein-coupled receptors (GPCRs) that are cleaved at an activation site within the N-terminal exodomain by a variety of proteinases, essentially of the serine (Ser) proteinase family. After cleavage, the new N-terminal sequence functions as a tethered ligand, which binds intramolecularly to activate the receptor and initiate signaling. Cell signals induced through the activation of PARs appear to play a significant role in innate and adoptive immune responses of the cornea, which is constantly exposed to proteinases under physiological or pathophysiological conditions...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/26065011/prostate-cancer-metastatic-to-bone-has-higher-expression-of-the-calcium-sensing-receptor-casr-than-primary-prostate-cancer
#29
Jie Feng, Xiaojun Xu, Bo Li, Edward Brown, Alton B Farris, Shi-Yong Sun, Jenny J Yang
The calcium-sensing receptor (CaSR) is the principal regulator of the secretion of parathyroid hormone and plays key roles in extracellular calcium (Ca(2+) o) homeostasis. It is also thought to participate in the development of cancer, especially bony metastases of breast and prostate cancer. However, the expression of CaSR has not been systematically analyzed in prostate cancer from patients with or without bony metastases. By comparing human prostate cancer tissue sections in microarrays, we found that the CaSR was expressed in both normal prostate and primary prostate cancer as assessed by immunohistochemistry (IHC)...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/26005699/estrogen-receptor-%C3%AE-signaling-and-localization-regulates-autophagy-and-unfolded-protein-response-activation-in-er-breast-cancer
#30
JOURNAL ARTICLE
Katherine L Cook, Robert Clarke
Antiestrogen therapy is commonly used to treat estrogen receptor (ER)+ breast cancers but acquired and de novo resistance limits their overall curative potential. An endoplasmic reticulum stress pathway, the unfolded protein response, and autophagy are both implicated in the development of antiestrogen therapy resistance in estrogen receptor-α (ER) positive breast cancer. Thus, we recently investigated how ERα can regulate autophagy and the unfolded protein response (Cook et al., FASEBJ, 2014). We showed that inhibiting ERα signaling stimulates autophagosome formation and flux...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/26005698/the-perk-of-being-a-target-kinase-regulation-of-the-orphan-nuclear-receptor-err%C3%AE
#31
JOURNAL ARTICLE
Rebecca B Riggins
Estrogen-related receptors (ERRs) are orphan members of the nuclear receptor superfamily that are important regulators of mitochondrial metabolism with emerging roles in cancer. In the absence of an endogenous ligand, ERRs are reliant upon other regulatory mechanisms that include protein/protein interactions and post-translational modification, though the cellular and clinical significance of this latter mechanism is unclear. We recently published a study in which we establish estrogen-related receptor gamma (ERRγ) as a target for extracellular signal-regulated kinase (ERK), and show that regulation of ERRγ by ERK has important consequences for the function of this receptor in cellular models of estrogen receptor-positive (ER+) breast cancer...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/25995992/plakophilin-2-induced-egfr-phosphorylation-a-focus-on-the-intracellular-activators-of-egfr
#32
Kei-Ichiro Arimoto, Stephanie Weng, Dong-Er Zhang
The oncogenic role of EGFR in many tumors has attracted a great deal of attention in the recent years and initiated the development of several potent EGFR inhibitors, which are used clinically for cancer treatment. However, the current therapeutic inhibition of EGFR signaling is limited to monoclonal antibodies that bind to the EGFR extracellular domain or tyrosine kinase inhibitors that block EGFR kinase activation directly. Despite the great promise of these inhibitors, a certain percentage of patients develop resistance to these therapies, highlighting the necessity for alternative therapeutic strategies based on our most current knowledge of the mechanisms of EGFR signaling...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/25590045/beta-2-adrenergic-receptor-methylation-influences-asthma-phenotype-in-the-school-inner-city-asthma-study
#33
Jonathan M Gaffin, Wanda Phipatanakul
Asthma is the most common chronic illness of childhood and inner city residents suffer a disproportionately high rate of asthma diagnosis and asthma morbidity. The School Inner City Asthma Study investigates the school classroom based environmental exposures that may lead to asthma morbidity in inner city school children with asthma. Within this cohort, we investigated the role of methylation at the promoter region of the beta-2-adrenergic receptor in relation to asthma morbidity. We found that high levels of methylation in the region studied was significantly associated with decreased report of dyspnea and trended towards significance for lower levels of asthma symptoms and airway obstruction...
2014: Receptors & Clinical Investigation
https://read.qxmd.com/read/25152898/regulation-of-androgen-receptor-by-e3-ubiquitin-ligases-for-more-or-less
#34
Bo Li, Wenfu Lu, Zhenbang Chen
Prostate cancer (PCa) primarily depends on the dysregulations of androgen receptor (AR) signaling pathway for the initiation and growth as well as recurrence after chemotherapy ([1]). Androgen deprivation therapy (ADT) effectively alleviates symptoms of the malignancy to arrest further growth of primary tumors or progression of metastasis in patients with advanced PCa. However, relapse occurs in many patients after a short period, and PCa cells eventually become insensitive to ADT - termed castration resistant prostate cancer (CRPC) ([2, 3])...
2014: Receptors & Clinical Investigation
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.